Pfizer Venture Investments
Corporate VCSeed–Late Stage · 6 people tracked
Investment thesis
Strategic venture investor that preserves founder independence by not taking product rights, offers Pfizer collaboration potential, drug-discovery and business development expertise, active China strategy, and pharma exits.
Team · 6 people
from the firm's website
What they invest in
from 13 of 44 portfolio companiesBiotech ×13Medical Devices ×6AI & Machine Learning ×4Deep Tech ×2Healthtech ×2Advanced Manufacturing ×1Enterprise Software ×1
HQs:United States×6Switzerland×1
Investments · 44 tracked
founders shown can be your intro pathBiotechCambridge, US
Colleen E. Cuffaro(Director)Michael Gilman(Executive Officer, Director)Carolyn E. Green(Director)Alan E. Walts(Director)David E. Neafus(Executive Officer)Raj Parekh(Director)
BiotechSan Diego, US
Kevin Finney(Executive Officer, Director)John Borkholder(Executive Officer)
BoardKristina Burow(Director)Thomas Cahill(Director)Timothy Anderson(Director)Philip J DeSouza(Director)
Cartography develops antibody-based cancer therapies using single-cell sequencing and computational biology to identify precise cellular targets.
AI & Machine LearningBiotechDeep TechMedical Devices
Max Mumbach(Founding Scientist, Target Discovery)Jeffrey Verboon(Founding Scientist, Computational Biology)Ansu Satpathy(Founder)Kevin Parker(Chief Executive Officer)
Crossbow Therapeutics develops TCR-mimetic antibody therapies designed to target cancer antigens by mimicking T-cell receptors, with a focus on treating solid tumors and hematologic malignancies.
AI & Machine LearningBiotechMedical DevicesCambridge, US
Alexander Nolte(Executive Officer)inAlexandra Cantley(Director)inDmitri Wiederschain(Executive Officer)inSakae Asanuma(Director)inCharles Baum(Director)inIrena Melnikova(Director)in
Immunos Therapeutics develops therapies for immuno-oncology and inflammatory diseases.
BiotechHealthtechMedical Devices
Mediartx develops novel therapies for patients with fibrotic diseases.
BiotechMedical DevicesBoston, US
Rahul Ballal, PhD(CEO)Paul Yaworsky, PhD(CSO)inRahul Ballal(Executive Officer, Director)Brian Hubbard(Director)Stacey Brenner(Executive Officer)David de Graaf(Director)
Mozart Therapeutics develops protein therapeutics focused on immunology and oncology treatments.
BiotechMedical Devices
Mark Davis(Scientific Co-Founder)K. Christopher Garcia(Scientific Co-Founder)Calvin Kuo(Scientific Co-Founder)Katie Fanning(President & Chief Executive Officer)
Mission Therapeutics develops first-in-class small molecule inhibitors of deubiquitylating enzymes (DUBs) as therapeutics for serious diseases including Parkinson's and other neurodegenerative conditions, heart and kidney disease, fibrosis, and rare mitochondrial diseases.
BiotechHealthtech
Resilience is a contract development and manufacturing organization (CDMO) that manufactures complex pharmaceutical products and active pharmaceutical ingredients to broaden access to medicines and protect biopharmaceutical supply chains against disruption.
Advanced ManufacturingBiotechEnterprise SoftwareBlue Ash, US
William S. Marth(Chief Executive Officer)
BoardRobert Nelsen
Ann Arbor, US
Daniel Rhodes(Executive Officer, Director)Matthew Martin(Executive Officer)Jeffrey Williams(Executive Officer, Director)
BoardChristopher O'Donnell(Director)David Rubin(Director)James Pavlik(Director)
Frequently asked questions
- What stage does Pfizer Venture Investments invest at?
- Pfizer Venture Investments invests at the Seed, Series A, Series B, Series C, Late Stage stages.
- What sectors does Pfizer Venture Investments focus on?
- Pfizer Venture Investments focuses on AI & Machine Learning, Biotech, Healthtech, Medical Devices.
- Does Pfizer Venture Investments lead rounds?
- Pfizer Venture Investments typically participates in rounds rather than leading them.
Similar investors
Amadeus Capital Partners is a UK-based deep tech venture capital firm founded in 1997 that invests from seed to growth stages across artificial intelligence, health, and sustainability-focused technologies.
B Capital Group is a multi-stage venture capital firm that backs founders across the company-building lifecycle, investing in technology, healthcare, and energy & resilience sectors.
Capricorn Partners is an independent manager of venture capital funds and Quest for Growth, backing innovative companies that use technology as a competitive advantage.
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
GV (formerly Google Ventures) is a venture capital firm backing companies across AI applications, healthcare, developer tools and security, and infrastructure.